Archive Page 2

Houghton report on Open Access published released

The JISC-funded report “Economic Implications of Alternative Scholarly Publishing Models: Exploring the costs and benefits” by John Houghton et al. was released today:

press release
full report (pdf)

From the report:

A reduction of revenue to the publishing industry, should it arise, would imply a reduction of activity and employment in the industry. Such adjustments are difficult for those concerned, but an economy is a dynamic system and, over the business cycle, is likely to achieve something close to ‘full employment’. As a result, the capital and labour no longer employed in publishing would be employed in an alternative activity. Given the relative size of the publishing industry and the rate at which alternative publishing models are being adopted, it is unlikely that the UK economy would have difficulty adjusting to such a change

Technorati Tags: ,

Einstein was smart, but Could He Play the Violin? – the winner of the synchroblogging contest

Enjoyed this:

Einstein was smart, but Could He Play the Violin? – the winner of the synchroblogging contest:
Today is PLoS ONE’s second anniversary and we’re celebrating by announcing that the winner of the second PLoS synchroblogging competition is SciCurious of the Neurotopia 2.0 blog.
“This fluent post captures the essence of the research and accurately communicates it in a style that resonates with both the scientific and lay community” – Liz Allen, PLoS.
Here is the winning entry, cross posted in its entirety:
====================
Einstein was smart, but Could He Play the Violin?
I already wrote one entry for PLoS ONE’s second birthday, but I’m feeling sparky today, and I think I like this paper better.
I don’t know about you guys, but when I was a sprog, my parents dragged me to music lessons. LOTS of music lessons. As of right now, I have been producing music of some type for the past 21 years straight. And I LOVE it.
Of course, I didn’t always love it. I remember my mother dragging me and my brother to lessons, making us sit down every day and practice (I was, and still am, no good with the practicing), and the fear and shakiness of recitals (heck, I still get that, and it’s been 21 years). In her time, Sci has actually “mastered” (it’s a debatable point), three different instruments (‘instruments’ is a loose term), and still uses one of them professionally on occasion. And if you can guess what they are, Sci will…do something cool. Like send you one of her favorite books. Or perhaps a tshirt with a molecule on it. Or perhaps some of her delicious cookies. Obviously, you can only guess if you don’t KNOW already (that means you, Dad). So there you go, contest open.
Anyway, years and years of music lessons. But the question is: did they do me any good? Does playing ‘Baby Mozart’ really do anything, and is anything achieved by starting your child on Suzuki when they are 2, other than the pain and misery of your child, and possibly an eventual love of music? Can it, perhaps, make me SMARTER?
ResearchBlogging.org Forgeard et al. “Practicing a musical instrument in childhood is associated with enhanced verbal ability and nonverbal reasoning” PLoS ONE, 2008.
And for the record, Einstein did play the violin. Apparently he was quite good.
There actually are several studies out there that show that techniques that you learn can “transfer” to other techniques, giving you a bit of an edge. This works best when you’re performing skills that are very similar to each other (like learning how to estimate the area of a square, and then learning how to estimate the area of a triangle). We know this happens for musicians in the development of fine motor skills. Once you’ve been playing the violin for a while, other things that require fine motor skills will come to you a bit easier (perhaps we should train all would-be surgeons on musical instruments, if you can master playing Rachmaninoff, brain surgery should be a piece of cake).
Of course, most of the studies that have been done are correlational in nature. Kids who play musical instruments have better motor skills. This could be due to the music, or the kids could play music because they have good motor skills. Good motor skills could be a development of things like the higher socio-economic class that often goes along with being taught music as a child, and thus parents are maybe able to put more effort to their development. The possibilities go on. Correlation is NOT causation.
The same thing goes for the correlation between musical learning and IQ. There was a modest correlation, but it could be just the effect of the extra lessons the kids were receiving, resulting in more time spent on focused attention and mastering a skill. Significant correlations have also been shown for music and verbal and language skills. Music lessons have been found to be correlated with increases in reading ability and phonetic comprehension. This actually leads me to a question: if language, reading, and phonetic comprehension are related to the pitch and tone of words, do children who are tone deaf have a harder time mastering reading and verbal skills? I think this might warrant a future PubMed search.
Unfortunately, all the previous tests tended to focus on the “transfer” of skills to not very related fields, like IQ. So in this study, the authors wanted to look at the effects of music learning on “near” transfers, skill closely related to music training: spatial reasoning, verbal abilities, nonverbal, and mathematical. They also looked for VERY closely related skills: fine motor control and auditory skill.
They grabbed a whole bunch of kids around 8-11 years old. Some played musical instruments, some didn’t (one of the problems with this study to me is that the control group is a good bit small than the instrumental group, 41 musicians vs 18 non). Kids were controlled for the socio-economic class of the parents. Average length of music training was close to five years. They also divided the kids up by whether or not they got Suzuki training, but ended up grouping them together, as Suzuki effects were no different from other instrumentalists.
Dang, they didn’t graph their data. Well, I shall fix. Because I can. People should be so grateful I do all their graphing…
graph1.png
There you go. So, as you can see from the graph (the pretty, pretty graph), musical kids scored a lot better on fine motor skills for left and right hand (the first two sets of bars). This is pretty expected, if you’re using fine motor skills a lot, presumably you’ll get better at them. The musical kids also did better when distinguishing tones and following melody lines, though interestingly, they didn’t show any improvements in rhythm. I wonder if this has anything to do with the kids of music the kids were studying. There wasn’t a single drummer in the bunch, it was all either piano or stringed instruments.
And finally, the kids with musical training scored a lot better (I know it doesn’t look like it, but the MANCOVA analysis uncovered a difference) on vocabulary testing. They outperformed their non-musical counterparts in both verbal ability (vocabulary) and non-verbal reasoning skills. They didn’t find any differences in math or spatial reasoning.
The authors hypothesize that music training may transfer skills to some other related domains. The other hypothesis is that music training doesn’t enhance a specific skill set, but rather your general intellectual ability. This would mean they would score higher on every test given. In fact, they DID score higher, but most of the time the scores didn’t reach significance.
Still, remember this is correlation, not causation. Families were of similar socio-ecoomic class and education, but that doesn’t mean they are all similar parents. Kids who take music lessons may have parents that are more involved in their intellectual development. Kids that persist in taking music lessons for a good chunk of time may have superior motivation. Correlation =/= causation.
But it’s still a cool paper, and no matter what, it’s quite clear that music lessons didn’t HURT. Time to tape your poor child to the piano bench!
Marie Forgeard, Ellen Winner, Andrea Norton, Gottfried Schlaug (2008). Practicing a Musical Instrument in Childhood is Associated with Enhanced Verbal Ability and Nonverbal Reasoning PLoS ONE, 3 (10) DOI: 10.1371/journal.pone.0003566

Trackback URL for this post:

http://www.plos.org/cms/trackback/429

Libraries shun Google/Microsoft in favour of Open Content Alliance

A New York Times story from last week:

Several major research libraries have rebuffed offers from Google and Microsoft to scan their books into computer databases, saying they are put off by restrictions these companies want to place on the new digital collections.

The research libraries, including a large consortium in the Boston area, are instead signing on with the Open Content Alliance

The key issue is the terms of Google & Microsoft deals that prevent making the scanned material available to other commercial search services. Google pays the scanning costs (estimated by NYT to be $30 per book) whereas the libraries have to share the costs if they go with OCA.

Technorati Tags: , , ,

Max Planck Society cancels Springer online deal over pricing

As reported in the Library Journal:

The Max Planck Society (MPS), a major German research organization, issued a strongly worded statement this week to announce it was cancelling access to Springer’s online collection of journals over pricing. The cancellation will take effect as of December 31, 2007. MPS Vice President Kurt Mehlhorn said negotiations to extend the deal failed because, according to an MPS evaluation based on factors including usage and comparisons with other publishers, Springer was intent on charging “approximately double the price” the organization regarded as “reasonable.” …

Heise Online explains:

The failure of the talks means that the various institutes will soon no longer be able to access the common pool of scientific literature via the research surface by the name of SpringerLink that the publishing house provides. The Society will now with the institutes most affected attempt to work out a strategy whereby the supply of indispensable scientific content can be ensure in a cost-effective way. Because the subscriptions taken out in 1997 included the electronic archive rights, which according to the contract stay in force beyond the termination of the same, the scientists will, however, continue to enjoy online access to the paid-for, older volumes of the journals.

In other words, the “Big Deal” arrangements have been cancelled but the underlying subscriptions continue. This isn’t the first such cancellation (and unlikely to be the last) but it is a high-profile row and must be embarrassing to Springer in its original home territory.

Technorati Tags:

Sermo – an unusual business model

A newish social networking site for US doctors, Sermo, has an unusual business model. The site is (unsurprisingly) free for doctors (and some 31,000 have apparently joined to date) and the owners have also promised to keep the site clear of advertising, because:

Sermo is extremely professional. It is free of advertising and pharmaceutical promotion

So how do they plan to make money? Their idea is based on

“information arbitrage”, the opportunity that arises when breaking medical insights intersect with the demand for actionable, market-changing events in healthcare

In other words, they want to charge pharmacos, financial institutions, healthcare companies and others to participate and listen in on the community:

Clients pay a subscription fee and in return can post questions to the Sermo community. If you vote on one of these postings, you may be financially rewarded for your astute observations.

Sermo made the news in a headline deal with Pfizer. The Wall Street Journal reported on 15 Oct:

Facing financial pressures as some of its best-selling products lose patent protection, Pfizer is looking for more-efficient ways to reach the doctors who prescribe its medicines. Under the arrangement, Pfizer-affiliated doctors will be able to talk candidly with the site’s 31,000 members, potentially giving the company insights into prescribing patterns and a way to show doctors data on its drugs.

As the WSJ notes, this looks like a risky strategy for both parties. It’s not obvious to me that doctors will prefer to “talk candidly” with Pfizer’s shills over having to endure advertising on the site, and given the attention the pharma industry has received for some of its more dubious marketing practices (such as ghost-writing) and what has been seen as its undue influence over the whole medical profession (including, let us not forget, medical publishing), the arrangements are likely to come under some scrutiny from regulators.

Technorati Tags: , ,

A Guide to Rights and Royalties Management Software

A report I wrote for ALPSP has recently been released: A Guide to Rights and Royalties Management Software. From the blurb:

Just published, this guide is designed to give an overview of the available rights and royalties software systems currently available. It provides an introduction and charts some of the main trends in the field and looks at the potential benefits offered by software systems for book and journal publishers. It offers a number of illustrative publisher case studies and lists and describes the software provided by over 20 of the leading providers.

It’s available from the ALPSP website at £40 for ALPSP members and £70 for non-members, but Amazon are offering it for £28.50.

Technorati Tags:

How to cite a blog in an academic paper

One measure of the growing importance of blogs in scientific/medical communication is that the US National Library of Medicine has now provided guidance on how to cite a blog entry in an academic paper.

All the research I have seen recently suggests that the number of scientists regularly reading scientific blogs is a very small proportion (certainly under 10% in most fields), and the proportion actively blogging is lower still, but there’s no doubt the trend is upwards.

Technorati Tags:

PLoS Hubs

PLoS has launched PLoS Hub for Clinical Trials, the first of a planned series of such Hubs:

Launched in September 2007, the PLoS Hub for Clinical Trials collects PLoS journal articles that relate to clinical trials. The Hub is a destination site for researchers to share their views and build a dynamic, interactive community.

Currently, the PLoS Hub for Clinical Trials features articles originally published in PLoS Clinical Trials, along with clinical trials articles from PLoS ONE.

In the future, this new resource will expand to include articles from all the PLoS titles that publish clinical trials. It will also feature open-access articles from other journals plus user-generated content.

Registered users can rate, discuss and annotate articles in the Hub. More details in the PLos FAQ at Questions about the PLoS Hubs

At present, the Hub is little more than a filtered view of articles from PLoS Clinical Trials and PLoS ONE (which PLoS Clinical Trial is being merged into). But it is interesting to see another publisher attempting to create a destination site for a particular research community – some others (albeit very different approaches) include Elsevier’s OncologySTAT and Topic Pages, and IOP Publishing’s community sites such as MedicalPhysics.org and Environmentalresearchweb.org.

Technorati Tags: , ,

Richard Charkin to move from Macmillan to Bloomsbury

Macmillan has just announced that Richard Charkin will leave his position as CEO of Macmillan (part of the privately held Holtzbrinck Group) to join Bloomsbury as Executive Director:

Richard Charkin moves on after ten years at Macmillan
26 September 2007: Macmillan announced today that Richard Charkin will leave his post as CEO after exactly ten years with the company. He will take up a new position as Executive Director of Bloomsbury plc on Monday 1 October 2007.

Richard commented, “It is exactly ten years since I accepted the job as Chief Executive of Macmillan and it has been the best ten years of my career. I have been able to work in a company with strong values and traditions owned by a family committed to quality, innovation and autonomy

Apparently this means an end to Charkin’s delightful Chark Blog, though surely this can’t be allowed to happen?

What it means is that I won’t have to think of something to write about every morning on this blog. Just for the record we’ve had 1,137,267 visitors and generated $338.37 in advertising income. More importantly I’ve made new friends, learned tons and had fun. Thanks to all of you and pip pip from charkinblog.

Technorati Tags:

Elsevier’s OncologySTAT

It will be worth keeping an eye on Elsevier’s newly launched OncologySTAT, which provides advertising-supported free access for registered users to over 100 Elsevier oncology journals (press release).

The site will provide a lot of information.

OncologySTAT integrates a multitude of authoritative professional cancer information sources, such as peer-reviewed research, news and regulatory updates, a professional drug monograph and interactions database, chemotherapy regimens, and conference coverage into one easy-to-use online destination. Information and educational materials are delivered across multiple media formats: text, audio, video, interactive, user-generated forums, etc. Community oncologists and cancer-care practitioners in private practice or a non-institutional setting will find OncologySTAT especially useful in gaining immediate integrated access to the latest evidence-based research, news, treatment, and decision support information.

Specific sources of information include:

  • Peer-reviewed Journal Articles: registered users can search and access current journal articles from over 100 Elsevier cancer related journals including The Lancet Oncology, The Breast, Lung Cancer, Cancer Letters, The American Journal of Medicine, Seminars in Oncology, Seminars in Radiation Oncology, Seminars in Hematology, Blood Reviews, etc.
  • Journal Scans: Weekly professional summaries of the most important scientific research from 25 leading cancer journals, including Journal of Clinical Oncology, Journal of the National Cancer Institute, CA: A Cancer Journal for Clinicians, Blood, JAMA, and New England Journal of Medicine.
  • Cancer News Feeds: Late-breaking regulatory and drug approval updates from the widely respected Pink Sheet, as well as professional medical and conference news from the International Medical News Group and MDConsult.
  • InfoBlast E-Newsletter: A weekly e-newsletter highlighting key oncology news, research and site content features.
  • Integrated MEDLINE Search: Immediate access to search MEDLINE’s vast repository of scientific abstracts without exiting OncologySTAT.
  • Cancer-type “Spotlights”: 27 cancer type “Spotlight” sections featuring news, journals, article scans, clinical texts summaries, patient handouts and webinars on cancers such as bone, breast, prostate and lung.
  • Chemotherapy Regimens: Guidelines and protocols from the Elsevier Guide to Oncology Drugs and Regimens (2006) obtained through searches by drug or cancer type.
  • Professional Drug Monograph and Interactions Database: Powered by Gold Standard.

Access to Elsevier’s journals appears to be limited to search-based access, i.e. any articles you can find you can download but there is no access via table of contents. The advanced search options are very limited, for instance there is no fielded search for author, title, abstract, or journal, and I could not see any way of saving a search to run as a regular alert. These restrictions are presumably made in order to protect the subscriptions of the journals covered.

There are also some “community” features including blogs and forums, user biogs, and users can comment on journal articles and other content. The site is, however, much more focussed on a portal model than an out-and-out community and user-generated content approach.

The New York Times did an article too.

Technorati Tags: , ,

« Previous PageNext Page »


LinkedIn

LinkedIn button

RSS feed for this blog

Subscribe via email

Categories

Twitter